Incidence and survival patterns of cutaneous T-cell lymphomas in the United States

被引:104
作者
Imam, Muhammad Hassaan [1 ]
Shenoy, Pareen J. [2 ]
Flowers, Christopher R. [2 ]
Phillips, Adrienne [3 ]
Lechowicz, Mary Jo [2 ]
机构
[1] Emory Univ, Dept Internal Med, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
[3] Columbia Univ, Dept Med Hematol Oncol, New York, NY USA
关键词
Cutaneous T-cell lymphoma; incidence; treatment outcome; racial disparities; MYCOSIS-FUNGOIDES; EUROPEAN-ORGANIZATION; SEZARY-SYNDROME; EORTC CLASSIFICATION; RACIAL-DIFFERENCES; TASK-FORCE; CANCER; LEUKEMIA; EPIDEMIOLOGY; SUBTYPES;
D O I
10.3109/10428194.2012.729831
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using the United States Surveillance, Epidemiology and End Results (SEER) 17 dataset, we examined incidence and survival patterns for patients with cutaneous T-cell lymphomas (CTCLs) diagnosed following institution of the World Health Organization-European Organisation for Research and Treatment of Cancer (WHO-EORTC) classification. From 2005 to 2008, 2273 cases of CTCL were diagnosed. The age-adjusted incidence rate per 100 000 person-years for mycosis fungoides (MF) was 0.55 and for Sezary syndrome (SS) was 0.01. Incidence was higher among males (MF/SS male-to-female incidence rate ratio [IRR] 1.57) and black patients (MF black-to-white IRR 1.55). Black patients with CTCL were diagnosed at a younger age and black patients with MF/SS presented with advanced stage and had worse survival than white patients. In multiple-variable Cox-regression models, age >60 (hazard ratio [HR] 4.78, 95% confidence interval [CI] 2.97-7.70), black race (HR 2.09, 95% CI 1.29-3.37) and advanced stage (HR 6.06, 95% CI 3.66-10.05) predicted worse survival for patients with MF/SS. Additional research identifying reasons for these differences are necessary to better understand these diseases and for new strategies in the treatment of CTCL.
引用
收藏
页码:752 / 759
页数:8
相关论文
共 48 条
[1]   Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States [J].
Abouyabis, Abeer N. ;
Shenoy, Pareen J. ;
Lechowicz, Mary Jo ;
Flowers, Christopher R. .
LEUKEMIA & LYMPHOMA, 2008, 49 (11) :2099-2107
[2]  
[Anonymous], **NON-TRADITIONAL**
[3]  
[Anonymous], 2013, International Classification of disease for Oncology
[4]  
[Anonymous], 2010, Cancer
[5]  
[Anonymous], 2011, ISRN HEMATOL
[6]  
Assaf Chalid, 2007, J Dtsch Dermatol Ges, V5, P662, DOI 10.1111/j.1610-0387.2007.06337.x
[7]   Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases [J].
Bradford, Porcia T. ;
Devesa, Susan S. ;
Anderson, William F. ;
Toro, Jorge R. .
BLOOD, 2009, 113 (21) :5064-5073
[8]   THE STATISTICAL COMPARISON OF RELATIVE SURVIVAL RATES [J].
BROWN, CC .
BIOMETRICS, 1983, 39 (04) :941-948
[9]  
BUNN PA, 1979, CANCER TREAT REP, V63, P725
[10]   Changes in cancer registry coding for lymphoma subtypes: Reliability over time and relevance for surveillance and study [J].
Clarke, CA ;
Undurraga, DM ;
Harasty, PJ ;
Glaser, SL ;
Morton, LM ;
Holly, EA .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (04) :630-638